Navigation Links
PharmSource Introduces Proprietary Resource for Identifying New Business Opportunities in Bio/Pharma
Date:11/24/2008

PharmSource Lead Sheet upgrades database resources to help companies serving biotech/pharma industry to find new business opportunities and market intelligence.

Springfield, VA (PRWEB) November 24, 2008 -- In response to challenging economic times, PharmSource Information Services, Inc. (PharmSource) announces the expansion of its PharmSource Lead Sheet, a weekly web-based service that reports new business opportunities and market intelligence information to companies that serve the biotechnology/pharmaceutical industry.

The newest capability, known as the Qualifying Information Search, enables detailed database searches for biotech/pharma companies world-wide, based on criteria including: company ownership status (public/private), number of employees, annual R&D expenditure amounts, annual revenue amounts, venture capital sources and geographic locations. Search results are delivered via a downloaded spreadsheet. This robust new feature allows users to quickly qualify and manage prospects directly from their desktops, enabling a highly streamlined and effective lead management process.

About the PharmSource Lead Sheet
PharmSource's scientific research team identifies and qualifies new opportunities in the drug development pipeline, including product status changes and bio/pharma alliances and financings. This information signals new opportunities for contract manufacturers and other biotech/pharma vendors. The Lead Sheet electronically delivers up to 70+ new, global business opportunities each week. Available by annual subscription, PharmSource currently offers a complimentary trial of the PharmSource Lead Sheet to qualified companies.

About PharmSource
PharmSource Information Services, Inc. is a respected provider of business intelligence on contract drug development and manufacture. PharmSource assists biotechnology and pharmaceutical companies in implementing and managing sourcing strategies and programs. PharmSource also provides business development products and services to companies that serve the biotech/pharma industries. Since 1996, organizations involved in contract Pharma services have continuously relied on PharmSource databases, publications, surveys and consulting services to provide timely, accurate information and analysis. Visit PharmSource on the web at http://www.pharmsource.com or contact them at 703-383-4903 (ET).

# # #

Read the full story at http://www.prweb.com/releases/2008/11/prweb1656804.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models
2. Bio-Tec Environmental Introduces Their New Plastic Additive Showing 45% Biodegradation of Plastics in Just 14 Days
3. LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates
4. Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research
5. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Nanoscience Instruments, Inc. Introduces All-Diamond AFM Probes
8. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
9. LI-COR Introduces the Odyssey(R) Two-Color NIR Fluorescent Protein Molecular Weight Marker
10. SoluLinK Introduces New One-Shot ChromaLink(TM) Biotin Antibody Labeling Kit with Built-in Biotin Quantification.
11. World Leader in Bench Top Flow Chemistry Instruments ThalesNano, Inc. Introduces an Industry First Seminar Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. ... Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
Breaking Biology Technology:
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):